Table 2.
Baseline characteristics of the propensity-score-matched cohort.
| Analysis | Cohort | Standard care | Nasal irrigation | Notes |
|---|---|---|---|---|
| Primary binary symptom analysis, VAS ≥3 | Matched cohort | 74 | 74 | Main analysis |
| Longitudinal symptom-score GEE | Matched cohort | 74 | 74 | Four follow-up time points |
| Rescue-medication burden analysis | Matched cohort | 74 | 74 | Duration and total dose count |
| Imaging T/B ratio analysis | Matched cohort | 74 | 74 | Day 3 and day 7 |
| Rescue medication use | Original cohort | 30/92 (32.6%) | 13/93 (14.0%) | n/% |
| Rescue medication use | Matched cohort | 25/74 (33.8%) | 10/74 (13.5%) | n/% |
| VAS ≥4 sensitivity analysis | Original cohort | 29/92 (31.5%) | 13/93 (14.0%) | Exploratory; not PSM-based |